What is MOUD/MAT?

Medication for Opioid Use Disorder (MOUD) or Medication Assisted Treatment (MAT) is an important evidence-based treatment option for individuals with Opioid Use Disorders (OUDs). These medications help reduce cravings and withdrawal symptoms that come from stopping opioid use.

 

MOUD/MAT provides a safe, controlled level of medication to overcome the use of a problem opioid. Methadone is one MOUD that has a long history of use in specialty addictions clinics. Buprenorphine and naltrexone, newer medications, are other forms of MOUD that can also be used for treatment in office-based settings. 

 

The Drug Addiction Treatment Act of 2000 allows prescribers who complete additional training to obtain a waiver to use buprenorphine for the treatment of OUDs. This has increased the availability of treatment. The medication’s pharmacological properties make it safe and appropriate for use in settings outside of addictions clinics (or “office-based” care). Our program can help providers determine if a particular patient is a good candidate for office-based care.

The Michigan Opioid Collaborative can help providers give guidance and recommendations on the patient monitoring required to ensure safe medication use.

Some patients report that they prefer to receive MOUD in a physician’s office.  This is often seen as a more confidential way to seek treatment and can help patients to avoid exposure to others in the drug culture.  This form of treatment can also help patients who want treatment that does not interfere with their full time employment and family commitments.  In some cases, receiving MOUD from a primary care physician may improve a patient’s engagement in treatment for other health conditions.